Feb. 13, 2022
MIW815 (ADU-S100)
STING agonist Ph. II candidate for met. H&N cancer from SBDD of endogenous ligand Clin. Cancer Res. Aduro (Chinook Therapeutics)
STING agonist Ph. II candidate for met. H&N cancer from SBDD of endogenous ligand Clin. Cancer Res. Aduro (Chinook Therapeutics)